
    
      A single center, prospective cohort, open-label study of rabies post exposure program with
      equine rabies immunoglobulin (ERIG) and purified chick-embryo cell (PCEC) rabies vaccine in
      WHO category III exposed patients at Siriraj Hospital, Thailand aims to compare serum RVNA
      responses between obese (BMI > 30 kg/m2) and normal weight/underweight (BMI < 25 kg/m2) and
      to evaluate adverse events occurring after immunization on days 7, 14 and 28.
    
  